Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jun 15, 2026; 18(6): 117912
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.117912
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.117912
Table 4 Comparison of survival indicators between the two groups
| Survival indicators (%) | Control group (n = 80) | Experimental group (n = 80) | Statistics | P value |
| Survival rate for one year | 62.50 | 85.00 | χ2= 10.460 | 0.001 |
| Survival rate for two years | 37.50 | 60.00 | χ2= 8.105 | 0.004 |
| Survival rate for three years | 22.50 | 43.75 | χ2= 8.154 | 0.004 |
| Median disease-free survival (months) | 19.00 | 31.60 | Log-rank = 12.898 | < 0.001 |
- Citation: Liu B, Su N, Lin QS, Huang YQ, Chen SF. Investigation of interaction between sodium-glucose cotransporter 2 inhibitors and FOLFOX with colorectal cancer and type 2 diabetes. World J Gastrointest Oncol 2026; 18(6): 117912
- URL: https://www.wjgnet.com/1948-5204/full/v18/i6/117912.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i6.117912